Blog
Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLC
Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLC
Form 8.3 - The Vanguard Group, Inc.: Schroders PLC
Form 8.3 - The Vanguard Group, Inc.: Schroders PLC
Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Ltd
Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Ltd
Form 8.3 - The Vanguard Group, Inc.: NCC Group PLC
Form 8.3 - The Vanguard Group, Inc.: NCC Group PLC
Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property PLC
Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property PLC
Form 8.3 - The Vanguard Group, Inc.: Just Group PLC
Form 8.3 - The Vanguard Group, Inc.: Just Group PLC
Form 8.3 - The Vanguard Group, Inc.: JTC PLC
Form 8.3 - The Vanguard Group, Inc.: JTC PLC
Form 8.3 - The Vanguard Group, Inc.: British Land Co PLC/The
Form 8.3 - The Vanguard Group, Inc.: British Land Co PLC/The
Form 8.3 - The Vanguard Group, Inc.: Beazley PLC
Form 8.3 - The Vanguard Group, Inc.: Beazley PLC
PATRIMOINE ET COMMERCE: 2025 ANNUAL RESULTS
PATRIMOINE ET COMMERCE: 2025 ANNUAL RESULTS
First day of trading on Euronext Growth Oslo
First day of trading on Euronext Growth Oslo
EQS-News: Baader Bank to partner with Nordea on research and corporate access
EQS-News: Baader Bank to partner with Nordea on research and corporate access
EQS-News: Intershop publishes preliminary figures for the financial year 2025
EQS-News: Intershop publishes preliminary figures for the financial year 2025
EQS-News: SAF-HOLLAND SE: Preliminary results for fiscal year 2025 show solid profitability in a challenging market environment
EQS-News: SAF-HOLLAND SE: Preliminary results for fiscal year 2025 show solid profitability in a challenging market environment
Straumann Group delivers strong 2025 performance with continued market share gains, innovation and strategic progress
Straumann Group delivers strong 2025 performance with continued market share gains, innovation and strategic progress
Sandoz receives US FDA approval to expand Enzeevu® (aflibercept-abzv) label for multiple retinal indications
Sandoz receives US FDA approval to expand Enzeevu® (aflibercept-abzv) label for multiple retinal indications
Amrize Delivers Strong Free Cash Flow in 2025; Shareholder Return Plan Proposed
Amrize Delivers Strong Free Cash Flow in 2025; Shareholder Return Plan Proposed
EQS-News: Immunic Announces Closing of Oversubscribed Private Placement Financing
EQS-News: Immunic Announces Closing of Oversubscribed Private Placement Financing
Fuller, Smith & Turner PLC: Transaction in own shares
Fuller, Smith & Turner PLC: Transaction in own shares
Avolta secures major dining contract at Toronto Pearson
Avolta secures major dining contract at Toronto Pearson
EQS-News: Amadeus Fire Group demonstrates resilience in a challenging economic environment – 2025 revenue and operating EBITA in line with guidance
EQS-News: Amadeus Fire Group demonstrates resilience in a challenging economic environment – 2025 revenue and operating EBITA in line with guidance
EQS-News: Enapter AG: Armin Steiner steps down from the Supervisory Board – Ragnar Kruse elected Chairman
EQS-News: Enapter AG: Armin Steiner steps down from the Supervisory Board – Ragnar Kruse elected Chairman
EQS-Adhoc: Dürr AG exceeds forecast for earnings after tax in fiscal 2025
EQS-Adhoc: Dürr AG exceeds forecast for earnings after tax in fiscal 2025
2CRSi SA: 2CRSi Secures a €140 Million Contract
2CRSi SA: 2CRSi Secures a €140 Million Contract
EQS-Adhoc: Bayer Aktiengesellschaft: Monsanto announces Roundup™ class settlement agreement to resolve current and future claims
EQS-Adhoc: Bayer Aktiengesellschaft: Monsanto announces Roundup™ class settlement agreement to resolve current and future claims


